New drug combo could treat some resistant breast cancers: Newsroom - UT Southwestern, Dallas, Texas
Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer | npj Breast Cancer
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now | npj Breast Cancer
Narratives on Collaboration
What is HER2-positive Breast Cancer? | PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx)
HER2 splice variants in breast cancer: investigating their impact on diagnosis and treatment outcomes | Oncotarget
Frontiers | Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients
HER2 Therapies for Patients with mCRC
HER2 - Wikipedia
Chromosome 17 loci of HER2 and other genes associated with... | Download Scientific Diagram
Identification of HER2 amplification: (1) gene amplification, (2)... | Download Scientific Diagram
HER2 Amplification or Overexpression in Upper GI Tract and Breast Cancer with Clinical Diagnosis and Treatment | IntechOpen
Herceptin
HER2| Breast Cancer |Gastric Cancer | Lung Cancer | OriGene
HER2-Driven Carcinogenesis: New Mouse Models for Novel Immunotherapies | IntechOpen
HER2 Biomarker in Colon Cancer | Know Your Biomarker
What is HER2+ Metastatic Breast Cancer? | KADCYLA® (ado-trastuzumab emtansine)
HER2 - Wikipedia
HER2 Genetic Link to Breast Cancer - NCI
Cancers | Free Full-Text | Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? | SpringerLink
AstraZeneca on X: "Approx. 20-30% of #breastcancer have a faulty HER2 gene which makes too many copies of itself – this is known as gene amplification. This results in more HER2 receptors
IJMS | Free Full-Text | Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization
